Upper Tract Urothelial Carcinoma: An Update on Current Diagnostic Modalities and Emerging Biomarkers
There is an urgent need for non-invasive biomarkers that can reliably replace diagnostic ureteroscopies, identify high-risk/invasive disease and select patients for radical surgery or kidney sparing procedures.
Authors
- Amy Nagle
- L. Tzelves
- Ioannis Manolitsis (ORCID: https://orcid.org/0000-0003-1496-0742)
- Mohammad Sharif
- Ioannis Loufopoulos (ORCID: https://orcid.org/0009-0001-8118-1493)
- Konstantinos Kapriniotis (ORCID: https://orcid.org/0000-0002-7411-9181)
- James Green (ORCID: https://orcid.org/0000-0003-4846-5192)
Institutions
- National and Kapodistrian University of Athens (GR)
- Aberdeen Royal Infirmary (GB)
- The Royal Free Hospital (GB)
- Whipps Cross University Hospital (GB)
- University College London (GB)
Publication Details
- Journal
- Journal of Personalized Medicine
- Published
- 2026-04-16
- DOI
- https://doi.org/10.3390/jpm16040220
- Primary Topic
- Bladder and Urothelial Cancer Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00